Cargando…

Jumonji domain-containing protein 6 functions as a marker of head and neck squamous cell carcinoma at advanced stage with no effect on prognosis

A number of studies have reported the upregulation and functional roles of Jumonji domain-containing protein 6 (JMJD6) in various types of cancer. However, little is known regarding the clinical significance of JMJD6 in head and neck squamous cell carcinoma (HNSCC), particularly in terms of large-co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Bing, Wang, Lei, Qin, Xingjun, Shen, Yi, Ma, Chunyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865058/ https://www.ncbi.nlm.nih.gov/pubmed/31788057 http://dx.doi.org/10.3892/ol.2019.10938

Ejemplares similares

Jumonji domain‐containing protein 6 protein and its role in cancer
por: Yang, Jing, et al.
Publicado: (2020)

Transcriptional and post-transcriptional control of adipocyte differentiation by Jumonji domain-containing protein 6
por: Hu, Yu-Jie, et al.
Publicado: (2015)

Cooperation between ETS variant 2 and Jumonji domain-containing 2 histone demethylases
por: Li, Xiaomeng, et al.
Publicado: (2018)

Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia
por: Koca, Duygu, et al.
Publicado: (2020)

Kinetic and inhibition studies on human Jumonji-C (JmjC) domain-containing protein 5
por: Tumber, Anthony, et al.
Publicado: (2023)

HIF-1-Dependent Induction of Jumonji Domain-Containing Protein (JMJD) 3 under Hypoxic Conditions
por: Lee, Ho-Youl, et al.
Publicado: (2014)

Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer
por: Zheng, Heng, et al.
Publicado: (2019)

A New Family of Jumonji C Domain-Containing KDM Inhibitors Inspired by Natural Product Purpurogallin
por: Souto, José A., et al.
Publicado: (2020)

Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers
por: He, Chenchen, et al.
Publicado: (2023)

Involvement of a Jumonji-C domain-containing histone demethylase in DRM2-mediated maintenance of DNA methylation
por: Deleris, Angelique, et al.
Publicado: (2010)

Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model
por: Yang, Cheng-Yu, et al.
Publicado: (2020)

Role of Jumonji domain-containing protein D3 and its inhibitor GSK-J4 in Hashimoto’s thyroiditis
por: Lu, Xixuan, et al.
Publicado: (2023)

Colonic vitamin D receptor expression is inversely associated with disease activity and jumonji domain-containing 3 in active ulcerative colitis
por: Wang, Hong-Qian, et al.
Publicado: (2020)

Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3
por: Jung, Ji-Won, et al.
Publicado: (2010)

Jumonji domain-containing protein 1A promotes cell growth and progression via transactivation of c-Myc expression and predicts a poor prognosis in cervical cancer
por: Liu, Jue, et al.
Publicado: (2016)

Effects of siRNA-mediated knockdown of jumonji domain containing 2A on proliferation, migration and invasion of the human breast cancer cell line MCF-7
por: LI, BEI-XU, et al.
Publicado: (2012)

Jumonji C Demethylases in Cellular Senescence
por: Leon, Kelly E., et al.
Publicado: (2019)

Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Taberna, Miren, et al.
Publicado: (2019)

Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer
por: Chen, L, et al.
Publicado: (2014)

Genome-wide identification of the jumonji C domain- containing histone demethylase gene family in wheat and their expression analysis under drought stress
por: Wang, Xinhua, et al.
Publicado: (2022)

Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma
por: FANG, LIPING, et al.
Publicado: (2016)

Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma
por: Fang, Liping, et al.
Publicado: (2016)

Jumonji domain containing protein 6 (Jmjd6) modulates splicing and specifically interacts with arginine–serine-rich (RS) domains of SR- and SR-like proteins
por: Heim, Astrid, et al.
Publicado: (2014)

CCTs as new biomarkers for the prognosis of head and neck squamous cancer
por: Dong, Yanbo, et al.
Publicado: (2020)

Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma
por: Wang, Han-Qi, et al.
Publicado: (2023)

A potential common role of the Jumonji C domain-containing 1A histone demethylase and chromatin remodeler ATRX in promoting colon cancer
por: Li, Xiaomeng, et al.
Publicado: (2018)

Histone demethylase Jumonji domain‐containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt‐related transcription factor 3
por: Ning, Ke, et al.
Publicado: (2020)

5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5
por: Brewitz, Lennart, et al.
Publicado: (2023)

The roles of Jumonji-type oxygenases in human disease
por: Johansson, Catrine, et al.
Publicado: (2014)

Advances in the management of squamous cell carcinoma of the head and neck
por: Machiels, Jean-Pascal, et al.
Publicado: (2014)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
por: Xu, Xuanli, et al.
Publicado: (2021)

Jumonji domain containing 5 is a potential prognostic indicator in non-small cell lung cancer patients who received platinum-based chemotherapy
por: Xiang, Xueping, et al.
Publicado: (2019)

Genetic Variants Were Associated With the Prognosis of Head and Neck Squamous Carcinoma
por: He, Yingzheng, et al.
Publicado: (2020)

Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma
por: WEMMERT, SILKE, et al.
Publicado: (2016)

Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Yang, Zhi-Min, et al.
Publicado: (2022)

Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV
por: Moghe, Akshata, et al.
Publicado: (2017)

Identification of a Ferroptosis Gene Set That Mediates the Prognosis of Squamous Cell Carcinoma of the Head and Neck
por: Li, Chunyan, et al.
Publicado: (2021)

Roles of E2F family members in the diagnosis and prognosis of head and neck squamous cell carcinoma
por: Li, Yaoxu, et al.
Publicado: (2023)

Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma
por: Major, Aidan G., et al.
Publicado: (2013)

CTHRC1 is associated with immune cell infiltration and functions as an adverse marker for prognosis in head and neck squamous cell carcinoma
por: Zhong, Ruolei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_53iab9db5ooiop6tvu9stlkttr